LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Gianoncelli, Olivia"
  2. AU=Jacob R A
  3. AU="Schaub, Theres"
  4. AU="He, Shengqu"
  5. AU="Elec, Florin I"
  6. AU="I.S. Carneiro"
  7. AU="Jia, Dongzheng" AU="Jia, Dongzheng"
  8. AU="Hollis-Perry, Monique"
  9. AU="Duman, Duygu"
  10. AU="Abdullahi, Akilu"
  11. AU="Daniela Maymó"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Clinical efficacy of crushed prednisolone and hydrocolloid powder in the primary treatment of peristomal pyoderma gangrenosum and correlation to in vitro drug release data.

Pearson, Wendy Ann / Prentice, David Andrew / Lim, Lee Yong / Gianoncelli, Olivia / Hashiguchi, Alice / Parisella, Tahlia Kate / Ta, Jade Thien

International wound journal

2024  Band 21, Heft 3, Seite(n) e14808

Abstract: We evaluated the primary application of crushed prednisolone combined with hydrocolloid powder for clinically diagnosed peristomal pyoderma gangrenosum (PPG). We present our data on this cohort and follow-up of our previous patients. Of the 23 patients ... ...

Abstract We evaluated the primary application of crushed prednisolone combined with hydrocolloid powder for clinically diagnosed peristomal pyoderma gangrenosum (PPG). We present our data on this cohort and follow-up of our previous patients. Of the 23 patients who were commenced on this regime, 18 healed (78%). Twenty-two patients commenced on this regime as the primary treatment for their PPG, and for one, it was a rescue remedy after failed conventional therapy. Four patients with significant medical comorbidities failed to heal and one had their stomal reversal surgery before being fully healed. The proposed treatment regime for PPG is demonstrated to be effective, inexpensive and able to be managed in the patient's usual home environment. In vitro drug release analysis was undertaken, and data are presented to provide further insights into the efficacy of this regime.
Mesh-Begriff(e) Humans ; Prednisolone/therapeutic use ; Pyoderma Gangrenosum/drug therapy ; Pyoderma Gangrenosum/etiology ; Pyoderma Gangrenosum/diagnosis ; Powders/therapeutic use ; Drug Liberation ; Treatment Outcome
Chemische Substanzen Prednisolone (9PHQ9Y1OLM) ; Powders
Sprache Englisch
Erscheinungsdatum 2024-02-29
Erscheinungsland England
Dokumenttyp Journal Article
ZDB-ID 2170920-8
ISSN 1742-481X ; 1742-4801
ISSN (online) 1742-481X
ISSN 1742-4801
DOI 10.1111/iwj.14808
Signatur
Zs.A 6006: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang